Synergistic antibacterial effect of statins with the complex {[1-(4-bromophenyl)-3-phenyltriazene N 3 -oxide-κ 2 N 1 ,O 4 ](dimethylbenzylamine-κ 2 C 1 ,N 4 )palladium(II)}

Abstract The treatment of infections caused by resistant microorganisms represents a big challenge in healthcare due to limited treatment options. For this reason, the discovery of new active substances which are able to perform innovative and selective actions is of great impact nowadays. Statins a...

Full description

Bibliographic Details
Main Authors: Roberta Filipini Rampelotto, Vinicius Victor Lorenzoni, Danielly da Costa Silva, Guilherme A. de Moraes, Marissa Bolson Serafin, Maísa Kräulish Tizotti, Silvana Coelho, Priscilla Zambiazi, Manfredo Hörner, Rosmari Hörner
Format: Article
Language:English
Published: Universidade de São Paulo 2018-07-01
Series:Brazilian Journal of Pharmaceutical Sciences
Subjects:
Online Access:http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502018000200614&lng=en&tlng=en
_version_ 1818755865824460800
author Roberta Filipini Rampelotto
Vinicius Victor Lorenzoni
Danielly da Costa Silva
Guilherme A. de Moraes
Marissa Bolson Serafin
Maísa Kräulish Tizotti
Silvana Coelho
Priscilla Zambiazi
Manfredo Hörner
Rosmari Hörner
author_facet Roberta Filipini Rampelotto
Vinicius Victor Lorenzoni
Danielly da Costa Silva
Guilherme A. de Moraes
Marissa Bolson Serafin
Maísa Kräulish Tizotti
Silvana Coelho
Priscilla Zambiazi
Manfredo Hörner
Rosmari Hörner
author_sort Roberta Filipini Rampelotto
collection DOAJ
description Abstract The treatment of infections caused by resistant microorganisms represents a big challenge in healthcare due to limited treatment options. For this reason, the discovery of new active substances which are able to perform innovative and selective actions is of great impact nowadays. Statins and triazenes (TZC) have consolidated as a promising class of compounds, characterized by the expressive biological activity, especially antimicrobial activities. The aim of this study was to assess the in vitro synergistic antibacterial effect of the association of statins and a new TZC complex {[1-(4-bromophenyl)-3-phenyltriazene N 3-oxide-κ 2 N 1,O 4](dimethylbenzylamine-κ 2 C 1,N 4)palladium(II)} (Pd(DMBA)LBr) against American Type Culture Collection (ATCC) strains and clinical isolates. The complex and the statins showed bacterial activity of all tested strains and clinical isolates, evidencing that TZC complexion with metals can be promising. Simvastatin showed synergy when associated to the complex (FICI≤0.5), being the minimum inhibitory concentration (MIC) of 16 µg mL-1 found in 6 samples. Thus, it is possible to infer that the association between Pd(DMBA)LBr and simvastatin consists of an alternative to increase the pontential of these compounds, since statins have low toxicity.
first_indexed 2024-12-18T05:45:57Z
format Article
id doaj.art-1f6fb26fea1743ab9af8e2df7c5f7f32
institution Directory Open Access Journal
issn 2175-9790
language English
last_indexed 2024-12-18T05:45:57Z
publishDate 2018-07-01
publisher Universidade de São Paulo
record_format Article
series Brazilian Journal of Pharmaceutical Sciences
spelling doaj.art-1f6fb26fea1743ab9af8e2df7c5f7f322022-12-21T21:19:02ZengUniversidade de São PauloBrazilian Journal of Pharmaceutical Sciences2175-97902018-07-0154210.1590/s2175-97902018000217369S1984-82502018000200614Synergistic antibacterial effect of statins with the complex {[1-(4-bromophenyl)-3-phenyltriazene N 3 -oxide-κ 2 N 1 ,O 4 ](dimethylbenzylamine-κ 2 C 1 ,N 4 )palladium(II)}Roberta Filipini RampelottoVinicius Victor LorenzoniDanielly da Costa SilvaGuilherme A. de MoraesMarissa Bolson SerafinMaísa Kräulish TizottiSilvana CoelhoPriscilla ZambiaziManfredo HörnerRosmari HörnerAbstract The treatment of infections caused by resistant microorganisms represents a big challenge in healthcare due to limited treatment options. For this reason, the discovery of new active substances which are able to perform innovative and selective actions is of great impact nowadays. Statins and triazenes (TZC) have consolidated as a promising class of compounds, characterized by the expressive biological activity, especially antimicrobial activities. The aim of this study was to assess the in vitro synergistic antibacterial effect of the association of statins and a new TZC complex {[1-(4-bromophenyl)-3-phenyltriazene N 3-oxide-κ 2 N 1,O 4](dimethylbenzylamine-κ 2 C 1,N 4)palladium(II)} (Pd(DMBA)LBr) against American Type Culture Collection (ATCC) strains and clinical isolates. The complex and the statins showed bacterial activity of all tested strains and clinical isolates, evidencing that TZC complexion with metals can be promising. Simvastatin showed synergy when associated to the complex (FICI≤0.5), being the minimum inhibitory concentration (MIC) of 16 µg mL-1 found in 6 samples. Thus, it is possible to infer that the association between Pd(DMBA)LBr and simvastatin consists of an alternative to increase the pontential of these compounds, since statins have low toxicity.http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502018000200614&lng=en&tlng=enStatins/antimicrobial activityTriazenideAtorvastatinSimvastatin.
spellingShingle Roberta Filipini Rampelotto
Vinicius Victor Lorenzoni
Danielly da Costa Silva
Guilherme A. de Moraes
Marissa Bolson Serafin
Maísa Kräulish Tizotti
Silvana Coelho
Priscilla Zambiazi
Manfredo Hörner
Rosmari Hörner
Synergistic antibacterial effect of statins with the complex {[1-(4-bromophenyl)-3-phenyltriazene N 3 -oxide-κ 2 N 1 ,O 4 ](dimethylbenzylamine-κ 2 C 1 ,N 4 )palladium(II)}
Brazilian Journal of Pharmaceutical Sciences
Statins/antimicrobial activity
Triazenide
Atorvastatin
Simvastatin.
title Synergistic antibacterial effect of statins with the complex {[1-(4-bromophenyl)-3-phenyltriazene N 3 -oxide-κ 2 N 1 ,O 4 ](dimethylbenzylamine-κ 2 C 1 ,N 4 )palladium(II)}
title_full Synergistic antibacterial effect of statins with the complex {[1-(4-bromophenyl)-3-phenyltriazene N 3 -oxide-κ 2 N 1 ,O 4 ](dimethylbenzylamine-κ 2 C 1 ,N 4 )palladium(II)}
title_fullStr Synergistic antibacterial effect of statins with the complex {[1-(4-bromophenyl)-3-phenyltriazene N 3 -oxide-κ 2 N 1 ,O 4 ](dimethylbenzylamine-κ 2 C 1 ,N 4 )palladium(II)}
title_full_unstemmed Synergistic antibacterial effect of statins with the complex {[1-(4-bromophenyl)-3-phenyltriazene N 3 -oxide-κ 2 N 1 ,O 4 ](dimethylbenzylamine-κ 2 C 1 ,N 4 )palladium(II)}
title_short Synergistic antibacterial effect of statins with the complex {[1-(4-bromophenyl)-3-phenyltriazene N 3 -oxide-κ 2 N 1 ,O 4 ](dimethylbenzylamine-κ 2 C 1 ,N 4 )palladium(II)}
title_sort synergistic antibacterial effect of statins with the complex 1 4 bromophenyl 3 phenyltriazene n 3 oxide κ 2 n 1 o 4 dimethylbenzylamine κ 2 c 1 n 4 palladium ii
topic Statins/antimicrobial activity
Triazenide
Atorvastatin
Simvastatin.
url http://www.scielo.br/scielo.php?script=sci_arttext&pid=S1984-82502018000200614&lng=en&tlng=en
work_keys_str_mv AT robertafilipinirampelotto synergisticantibacterialeffectofstatinswiththecomplex14bromophenyl3phenyltriazenen3oxidek2n1o4dimethylbenzylaminek2c1n4palladiumii
AT viniciusvictorlorenzoni synergisticantibacterialeffectofstatinswiththecomplex14bromophenyl3phenyltriazenen3oxidek2n1o4dimethylbenzylaminek2c1n4palladiumii
AT daniellydacostasilva synergisticantibacterialeffectofstatinswiththecomplex14bromophenyl3phenyltriazenen3oxidek2n1o4dimethylbenzylaminek2c1n4palladiumii
AT guilhermeademoraes synergisticantibacterialeffectofstatinswiththecomplex14bromophenyl3phenyltriazenen3oxidek2n1o4dimethylbenzylaminek2c1n4palladiumii
AT marissabolsonserafin synergisticantibacterialeffectofstatinswiththecomplex14bromophenyl3phenyltriazenen3oxidek2n1o4dimethylbenzylaminek2c1n4palladiumii
AT maisakraulishtizotti synergisticantibacterialeffectofstatinswiththecomplex14bromophenyl3phenyltriazenen3oxidek2n1o4dimethylbenzylaminek2c1n4palladiumii
AT silvanacoelho synergisticantibacterialeffectofstatinswiththecomplex14bromophenyl3phenyltriazenen3oxidek2n1o4dimethylbenzylaminek2c1n4palladiumii
AT priscillazambiazi synergisticantibacterialeffectofstatinswiththecomplex14bromophenyl3phenyltriazenen3oxidek2n1o4dimethylbenzylaminek2c1n4palladiumii
AT manfredohorner synergisticantibacterialeffectofstatinswiththecomplex14bromophenyl3phenyltriazenen3oxidek2n1o4dimethylbenzylaminek2c1n4palladiumii
AT rosmarihorner synergisticantibacterialeffectofstatinswiththecomplex14bromophenyl3phenyltriazenen3oxidek2n1o4dimethylbenzylaminek2c1n4palladiumii